Mutation of anti-angiogenic sequences in the type I repeats of thrombospondin-1

被引：0
|
作者：
Chandrasekaran, L [1 ]
Roberts, DD [1 ]
机构：
[1] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1732
引用
收藏
页码：298A / 298A
页数：1
相关论文
共 50 条
  • [1] Therapies using anti-angiogenic peptide mimetics of thrombospondin-1
    Henkin, Jack
    Volpert, Olga V.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (12) : 1369 - 1386
  • [2] Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane
    S L Maloney
    D C Sullivan
    S Suchting
    J M J Herbert
    E M Rabai
    Z Nagy
    J Barker
    S Sundar
    R Bicknell
    [J]. British Journal of Cancer, 2009, 101 : 957 - 966
  • [3] Anti-angiogenic peptides identified in thrombospondin type I domains
    Karagiannis, Emmanouil D.
    Popel, Aleksander S.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 359 (01) : 63 - 69
  • [4] Biophysical characterization, including disulfide bond assignments, of the anti-angiogenic type 1 domains of human thrombospondin-1
    Huwiler, KG
    Vestling, MM
    Annis, DS
    Mosher, DF
    [J]. BIOCHEMISTRY, 2002, 41 (48) : 14329 - 14339
  • [5] The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts
    Jin, RJ
    Kwak, C
    Lee, SG
    Lee, CH
    Soo, CG
    Park, MS
    Lee, E
    Lee, SE
    [J]. CANCER GENE THERAPY, 2000, 7 (12) : 1537 - 1542
  • [6] Improvement of anti-angiogenic and anti-tumourigenic efficacy of thrombospondin-1 by PPARγ ligands in bladder cancer
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 38 - 38
  • [7] Improvement of anti-angiogenic and anti-tumorigenic efficacy of thrombospondin-1 by PPARy ligands in bladder cancer
    Nelius, Thomas
    Huang, Hanua
    Filleur, Stephanie
    Campbell, Steven C.
    de Riese, Werner
    Volpert, Olga
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 259 - 259
  • [8] Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression
    Menegazzo, L.
    Albiero, M.
    Milioni, R.
    Tolin, S.
    Arrigoni, G.
    Poncina, N.
    Tessari, P.
    Avogaro, A.
    Fadini, G.
    [J]. DIABETOLOGIA, 2013, 56 : S115 - S115
  • [9] Activation of Endoplasmic Reticulum Stress and Thrombospondin-1 Anti-Angiogenic Mechanisms in Placentas of Hypertensive Mice
    Marc, Casandra
    Achille, Allahnah
    Raguema, Nozha
    Pepin, Emilie
    Lavoie, Julie
    Bertagnolli, Mariane
    [J]. HYPERTENSION, 2019, 74
  • [10] Alternative Chemistries for the Synthesis of Thrombospondin-1 Type 1 Repeats
    Tiefenbrunn, Theresa K.
    Blanco-Canosa, Juan
    Dawson, Philip E.
    [J]. BIOPOLYMERS, 2010, 94 (04) : 405 - 413
12345